12 Health Care Stocks Moving In Wednesday's Pre-Market Session
Portfolio Pulse from Benzinga Insights
In Wednesday's pre-market session, several healthcare stocks experienced significant price movements. CNS Pharma, DBV Technologies, and Cyclacel Pharmaceuticals were among the top gainers, while Alto Neuroscience and Ensysce Biosciences saw notable declines.
October 23, 2024 | 12:08 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Alto Neuroscience shares dropped 62.3% in pre-market trading, indicating negative sentiment or news.
The sharp decline suggests negative news or sentiment, likely leading to short-term losses.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 100
NEGATIVE IMPACT
Ensysce Biosciences shares fell 18.58% in pre-market trading, reflecting negative market sentiment.
The decline in stock price suggests negative sentiment or news, likely leading to short-term losses.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
CNS Pharma shares surged 143.7% in pre-market trading, indicating strong investor interest.
The significant price increase suggests positive sentiment or news, likely leading to short-term gains.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100
POSITIVE IMPACT
Cyclacel Pharmaceuticals saw a 46.15% increase in pre-market trading, suggesting positive investor sentiment.
The significant price increase is indicative of positive news or investor sentiment, likely leading to short-term gains.
CONFIDENCE 85
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
DBV Technologies stock rose 62.87% in pre-market, reflecting positive market sentiment.
The substantial rise in stock price indicates strong investor interest, likely due to favorable news or developments.
CONFIDENCE 85
IMPORTANCE 75
RELEVANCE 100